Activity value 79ireland Buyer&Supplier,Last transaction date:
2026-02-07
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for eirgen pharma ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 2 transactions, with a transaction quantity of 41 and a transaction weight of 0.
YearTransactionsQuantityWeight
202547437.230
20262410
Bill of lading data
<
1/15
>
Trade date
2026/02/07
B/L No.
7182651
Suppliers
svak life sciences
Buyers
eirgen pharma ltd.
5hetero labs ltd.
indiasupplier,they trade on 2024-02-08
132.36%
>
+View All
Products
Total 68
ProductsTransactionsPerDetail
dos 1725.76%>
disc 1522.73%>
benperidol 1319.7%>
spare part 1015.15%>
olanzapine 812.12%>
+View All
Hscode rank
Total 34
HSCode NameTransactionsPerDetail
HS 294200903248.48%>
HS 842290901725.76%>
HS 2926900057.58%>
HS 2934999034.55%>
HS 3004904934.55%>
+View All
Trading Area
Total 1
AreaTransactionsPerDetail
india552100%>
Port statistics
Total 4
Port NameTransactionsPerDetail
dublin49790.04%>
cork447.97%>
waterford71.27%>
dub10.18%>
eirgen pharma ltd. is ireland Buyer&Supplier,
and primarily engages in the import and export business of products such as dos,disc,benperidol.
According to the 52wmb.com global trade database, as of 2026-02-07, the company has completed 625 international trades,
with its main trading regions covering india etc.
The core products include HS29420090,HS84229090,HS29269000 etc,
often transported via dublin,port cork, port waterford etc,
and its main trading partners are acg pam pharma technologies pvt ltd.,svak life sciences,natco pharma ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on eirgen pharma ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.